South Korea · Delayed Price · Currency is KRW Ildong Holdings Company Description
Ildong Holdings Co., Ltd. develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.
It develops new drugs against resistant bacteria, malignant tumors, Alzheimer’s disease, obesity, and ageing; and raw vitamins, probiotics, and antimicrobials, as well as offers Biovita, a lactobacillus product; and Aronamin, a multivitamin product.
It is also involved in the research and manufacture of health foods and ingredients; and provides hyaluronic acid for use in drugs, medical devices, and cosmetics.
In addition, the company distributes medical devices, quasi drugs, health supplements, food products, beverages, cosmetics, sanitary ware, and other healthcare products through online; and manufactures original and generic prescription drugs.
Further, it offers probiotics; pharmaceutical SI consulting, system development and deployment, RFID and barcode systems, and other solutions; and engages in advertising business.
The company was formerly known as Ildong Pharmaceutical Co., Ltd. and changed its name to Ildong Holdings Co., Ltd. in August 2016.
Ildong Holdings Co., Ltd. was founded in 1941 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1941 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 72 |
| CEO | Dae-Chang Park |
Contact Details
Address: 2, Baumoe-ro 27-gil Seoul, 06752 South Korea | |
| Phone | 82 2 526 3114 |
| Website | ildongholdings.co.kr |
Stock Details
| Ticker Symbol | 000230 |
| Exchange | Korea Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7000230003 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dae-Chang Park | Chief Executive Officer |
| Yong-Sik Kang | Managing Director and Director |